Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J McDermott

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
The Lancet. Neurology|June 16, 2016
Diaphragm pacing in patients with amyotrophic lateral sclerosis - Authors' replyChristopher J McDermott, Mike J Bradburn
Nature Reviews. Neurology|August 13, 2016
Supportive and symptomatic management of amyotrophic lateral sclerosisEsther V Hobson, Christopher J McDermott
Practical Neurology|February 12, 2017
Management of oral secretions in neurological diseaseAlexander J McGeachan, Christopher J Mcdermott
Disability and Rehabilitation. Assistive Technology|October 5, 2018
Communication change in ALS: engaging people living with ALS and their partners in future researchSimon Judge, Steven Bloch, Christopher J McDermott
Current Opinion in Neurology|August 12, 2014
The evidence for symptomatic treatments in amyotrophic lateral sclerosisThomas M Jenkins, Hannah Hollinger, Christopher J McDermott
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 3, 2019
Exploring patient and public involvement in motor neuron disease researchLucy S Musson, Christopher J McDermott, Esther V Hobson
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 6, 2009
Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidenceCeryl A Harwood, Christopher J McDermott, Pamela J Shaw
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 20, 2026
Timing of communication and technology control support in ALS - a systematic reviewSimon Judge, Kirsty Ballesteros, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 27, 2025
Exploring the needs and preferences of people with amyotrophic lateral sclerosis (ALS) when making genomic testing decisions: an interview studyJade Howard, Hilary L Bekker, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 2, 2024
A report of resources used by clinicians in the UK to support motor neuron disease genomic testingJade Howard, Hilary L Bekker, Christopher J Mcdermott, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
The Lancet. Neurology|June 16, 2016
Diaphragm pacing in patients with amyotrophic lateral sclerosis - Authors' replyChristopher J McDermott, Mike J Bradburn
Nature Reviews. Neurology|August 13, 2016
Supportive and symptomatic management of amyotrophic lateral sclerosisEsther V Hobson, Christopher J McDermott
Practical Neurology|February 12, 2017
Management of oral secretions in neurological diseaseAlexander J McGeachan, Christopher J Mcdermott
Disability and Rehabilitation. Assistive Technology|October 5, 2018
Communication change in ALS: engaging people living with ALS and their partners in future researchSimon Judge, Steven Bloch, Christopher J McDermott
Current Opinion in Neurology|August 12, 2014
The evidence for symptomatic treatments in amyotrophic lateral sclerosisThomas M Jenkins, Hannah Hollinger, Christopher J McDermott
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 3, 2019
Exploring patient and public involvement in motor neuron disease researchLucy S Musson, Christopher J McDermott, Esther V Hobson
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 6, 2009
Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidenceCeryl A Harwood, Christopher J McDermott, Pamela J Shaw
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 20, 2026
Timing of communication and technology control support in ALS - a systematic reviewSimon Judge, Kirsty Ballesteros, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 27, 2025
Exploring the needs and preferences of people with amyotrophic lateral sclerosis (ALS) when making genomic testing decisions: an interview studyJade Howard, Hilary L Bekker, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 2, 2024
A report of resources used by clinicians in the UK to support motor neuron disease genomic testingJade Howard, Hilary L Bekker, Christopher J Mcdermott, et al.
Pageof 17